Evidence map›Paper›PMID 34648572›Full record

ArticlePloS one2021

The CRL4VPRBP(DCAF1) E3 ubiquitin ligase directs constitutive RAG1 degradation in a non-lymphoid cell line.

N Max Schabla, Patrick C Swanson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

N Max SchablaDepartment of Medical Microbiology and Immunology, Creighton University, Omaha, Nebraska, United States of America.
Patrick C SwansonDepartment of Medical Microbiology and Immunology, Creighton University, Omaha, Nebraska, United States of America.ORCID 0000-0002-3290-6582
CHI Health Creighton University Medical Center - Bergan Mercy · US

Funding

Role of VprBP in B cell development and V(D)J recombinationR01GM102487 · NIGMS · CREIGHTON UNIVERSITY · PI SWANSON, PATRICK C. · 2012 to 2015
$1.2M
DCAF1(VprBP) regulates FoxO1 to promote Rag transcriptionR21AI146613 · NIAID · CREIGHTON UNIVERSITY · PI SWANSON, PATRICK C. · 2019 to 2020
$400k
Typhoon 9140S10RR027352 · NCRR · CREIGHTON UNIVERSITY · PI SWANSON, PATRICK C. · 2010 to 2010
$143k
NCRR NIH HHS S10 RR027352NIAID NIH HHS R21 AI146613NIGMS NIH HHS R01 GM102487
6 · The paper itself

Abstract

The development of B and T lymphocytes critically depends on RAG1/2 endonuclease activity to mediate antigen receptor gene assembly by V(D)J recombination. Although control of RAG1/2 activity through cell cycle- and ubiquitin-dependent degradation of RAG2 has been studied in detail, relatively little is known about mechanisms regulating RAG1 stability. We recently demonstrated that VprBP/DCAF1, a substrate adaptor for the CRL4 E3 ubiquitin ligase complex, is required to maintain physiological levels of RAG1 protein in murine B cells by facilitating RAG1 turnover. Loss of VprBP/DCAF1 in vivo results in elevated RAG1 expression, excessive V(D)J recombination, and immunoglobulin light chain repertoire skewing. Here we show that RAG1 is constitutively degraded when ectopically expressed in a human fibroblast cell line. Consistent with our findings in murine B cells, RAG1 turnover under these conditions is sensitive to loss of VprBP, as well as CRL4 or proteasome inhibition. Further evidence indicates that RAG1 degradation is ubiquitin-dependent and that RAG1 association with the CRL4VPRBP/DCAF1 complex is independent of CUL4 activation status. Taken together, these findings suggest V(D)J recombination co-opts an evolutionarily conserved and constitutively active mechanism to ensure rapid RAG1 turnover to restrain excessive RAG activity.

Indexed as

AnimalsB-LymphocytesCell LineHEK293 CellsHomeodomain ProteinsHumansImmunoglobulin Light ChainsMiceProtein Serine-Threonine KinasesProteolysisUbiquitinUbiquitin-Protein LigasesV(D)J RecombinationDCAF1 protein, humanHomeodomain ProteinsImmunoglobulin Light ChainsProtein Serine-Threonine KinasesRAG-1 proteinUbiquitinUbiquitin-Protein LigasesVprBP protein, mouse

Identifiers

PMID34648572
PMCPMC8516306
OpenAlexW3207015643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.